Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROSHARES TRUST (ZBIO) Treasury Shares: 2023-2025

  • Zenas BioPharma's Treasury Shares was N/A to $525,350 in Q3 2025 from the same period last year, while for Sep 2025 it was $525,350, marking a year-over-year change of. This contributed to the annual value of $21,172 for FY2024, which is 22.16% down from last year.
  • Latest data reveals that Zenas BioPharma reported Treasury Shares of $525,350 as of Q3 2025, which was up 2.79% from $511,100 recorded in Q2 2025.
  • Zenas BioPharma's 5-year Treasury Shares high stood at $525,350 for Q3 2025, and its period low was $21,172 during Q1 2024.
  • In the last 3 years, Zenas BioPharma's Treasury Shares had a median value of $27,200 in 2023 and averaged $221,199.
  • Data for Zenas BioPharma's Treasury Shares shows a maximum YoY dropped of 22.16% (in 2024) over the last 5 years.
  • Over the past 3 years, Zenas BioPharma's Treasury Shares (Quarterly) stood at $27,200 in 2023, then dropped by 22.16% to $21,172 in 2024, then reached $525,350 in 2025.
  • Its Treasury Shares was $525,350 in Q3 2025, compared to $511,100 in Q2 2025 and $21,172 in Q4 2024.